The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.
May 14th 2024
These results may support clinical decision-making for psoriasis and nail psoriasis management and may allow future real-world studies to further understand the nature of this skin disease.
Pursuing Pediatric Dermatology: Experiences Treating Epidermolysis Bullosa
In another interview segment, a discussion was held with medical student Brenda Abreu Molnar about her experiences with epidermolysis bullosa patients and the SPD’s 2022 Medical Student Mentorship Award.
April W. Armstrong, MD, MPH: Safety Profile of New Oral TYK2 Inhibitor for Psoriasis
In another segment of her interview, Armstrong explained the implications of her team’s findings for the newly-developed TYK2 inhibitor for plaque psoriasis, as well as its safety profile data.
Mark G. Lebwohl, MD: Psoriasis Drugs for Patients with Cancer, Obesity, Psoriatic Arthritis
In another segment of his interview, Mark Lebwohl, MD, discussed the various ways to address different psoriasis patients depending on their backgrounds with obesity, cancer, and psoriatic arthritis.